首頁 > 市場調查報告書 > 醫療設備

生物材料

市場調查報告書

商品編碼

1533651

生醫材料市場規模、佔有率和成長分析：按類型、應用和地區分類 - 產業預測，2024-2031 年

Biomaterials Market Size, Share, Growth Analysis, By Type (Natural Biomaterial, Metallic Biomaterial), Application (Neurology, Cardiology), By Region - Industry Forecast 2024-2031

出版日期: 2024年08月05日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年生醫材料市場規模將為1,354億美元，從2023年的1,559億美元成長到2031年的4,381億美元，預計在預測期內（2024-2031年）複合年成長率為15.4%。

生醫材料是人造材料，無論是合成的還是天然的，用於醫療技術中以改善受損組織和器官的功能。它們透過增強、替代和支持受損的生物功能，在醫療保健中發揮重要作用。這些材料可以源自金屬、陶瓷、塑膠、聚合物，甚至是活細胞和組織。常見應用包括醫療植入，如心臟瓣膜、支架、移植物、人工關節、韌帶、肌腱和人工植牙系統。生醫材料市場成長的驅動力是整形外科和創傷治療的使用增加、心血管、神經和整形外科疾病盛行率的上升、老年人口的增加、對植入設備的需求增加以及政府和學術機構的創新資金增加。

市場概況
金屬生醫材料
- 不銹鋼
- 鈦/鈦合金
- 鈷鉻合金
- 銀
- 金子
- 鎂
- 其他金屬生醫材料
高分子生醫材料
- 聚甲基丙烯酸甲酯
- 聚乙烯
- 聚酯纖維
- 聚氯乙烯
- 矽橡膠
- 尼龍
- 聚醚醚酮
- 其他高分子生醫材料
陶瓷生醫材料
- 磷酸鈣
- 氧化鋯
- 氧化鋁
- 硫酸鈣
- 碳
- 玻璃
天然生醫材料
- 玻尿酸
- 膠原蛋白
- 纖維蛋白
- 纖維素
- 甲殼質
- 藻酸鹽
- 明膠
- 幾丁聚醣
- 絲綢
- 其他天然生醫材料

生醫材料市場：依應用分類

市場概況
整形外科
- 關節重建手術
- 關節重建置換術
- 髖置換術
- 肩關節關節重建
- 其他關節重建手術
- 生物可吸收組織固定
- 縫合錨釘
- 網篩
- 超音波振動
- 干涉螺絲
- 半月軟骨修補術
- 網
- 脊椎手術
- 脊椎融合手術
- 微創融合術
- 運動保持/動態穩定化
- 椎弓根棒系統
- 棘突間活動式支架
- 人工椎間盤
- 骨折固定
- 骨板
- 擰緊
- 別針
- 桿
- 金屬絲
- 生物性骨材
心血管
- 導管
- 支架
- 植入
- 心律調節器
- 感應器
- 心臟瓣膜
- 血管移植
- 導管導引線
- 其他心血管產品
眼科
- 隱形眼鏡
- 人工水晶體
- 眼組織的功能性替代
- 人工角膜
- 其他眼科產品
牙科
- 人工植牙
- 牙科骨移植/人工骨骼替代物
- 牙膜
- 組織再生材料
整形外科
- 軟組織填充劑
- 顱顏外科產品
- 臉部皺紋治療設備
- 生物工程皮膚
- 周邊神經修復裝置
- 去細胞真皮基質
- 傷口癒合
- 傷口縫合裝置
- 縫合
- 訂書釘
- 手術止血鉗
- 內部組織密封膠
- 防沾黏屏障
- 疝氣網
- 皮膚替代品
組織工程
- 掃描摺疊
- 奈米材料
- 無機奈米粒子
神經系統/中樞神經系統
- 調車系統
- 皮質神經假體
- 水凝膠支架
- 神經幹細胞封裝產品
泌尿道
- 導尿管
- 尿道支架
- 其他尿製品
其他用途
- 藥物輸送系統
- 胃腸道
- 減重手術

生醫材料市場規模：按地區分類

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

BASF SE（Germany）
Covestro AG（Germany）
Celanese Corporation（Germany）
Carpenter Technology（US）
Olympus Terumo Biomaterials Corporation（Japan）
Evonik Industries AG（Germany）
Xylos Corporation（US）
Victrex Plc（UK）
Mitsubishi Chemical Holdings Corporation（Japan）
GELITA AG（Germany）
Corbion（Netherlands）
Solvay SA（US）
AB Specialty Silicones（US）
CoorsTek（US）
CeramTec GmbH（Germany）
Royal DSM NV（Netherlands）
The Lubrizol Corporation（US）
Berkeley Advanced Biomaterials（US）
Zeus Industrial Products, Inc.（US）
Noble Biomaterials, Inc.（US）
Dimension Inx（US）
Artoss, Inc.（US）
RDI Group（US）
Riton Biomaterial Co., Ltd.（China）
Cam Bioceramics（Netherlands）

簡介目錄

Product Code: SQMIG35H2027

Biomaterials Market size was valued at USD 135.4 billion in 2022 and is poised to grow from USD 155.9 billion in 2023 to USD 438.1 billion by 2031, growing at a CAGR of 15.4% in the forecast period (2024-2031).

Biomaterials, whether synthetic or natural, are engineered materials used in medical technology to improve the function of damaged tissues and organs. They play a crucial role in healthcare by helping to augment, replace, or support impaired biological functions. These materials can be derived from metals, ceramics, plastics, polymers, or even living cells and tissues. Common applications include medical implants like heart valves, stents, grafts, artificial joints, ligaments, tendons, and dental implants, as well as sutures, clips, and drug delivery systems that aid in tissue repair. The growth of the biomaterials market is driven by several factors: increasing use in plastic surgery and wound healing, rising incidences of cardiovascular, neurological, and orthopedic conditions, a growing elderly population, higher demand for implantable devices, and increased funding from governments and academic institutions for the development of innovative biomaterials.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biomaterials market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biomaterials Market Segmental Analysis

The global biomaterials market is segmented based on type, application, and region. Based on the type, the market is segmented into natural biomaterial, metallic biomaterial, ceramic biomaterial, and polymeric biomaterial. Based on the application, the market is segmented as neurology, cardiology, orthopedics, ophthalmology, wound care, dental, plastic surgery, and other applications. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Biomaterials Market

A major driver of growth in the biomaterials industry is the increased funding and grants provided by government agencies and universities for the development of innovative biomaterials. In recent years, the demand and application of biomaterials have significantly risen globally. To support this trend, numerous government bodies and institutions have offered financial assistance, including investments and grants, to foster research and development in this field. For instance, the National Science Foundation awarded Drexel University $200,000 to investigate how biomaterial-mediated control of macrophage behavior impacts biomaterial vascularization. Such funding and research initiatives are expected to accelerate the development of new biomaterials, presenting substantial growth opportunities for the market.

Restraints in the Global Biomaterials Market

A significant challenge to the growth of the biomaterials industry is the stringent clinical and regulatory processes that govern their approval. Biomaterials, particularly those used in implantable medical devices, are subject to rigorous safety and efficacy requirements before they can be marketed. In the United States, the FDA imposes strict standards for these approvals. Devices such as implantable pacemakers, stents, and cardiac valves are classified as Class III by the FDA, which signifies the highest level of risk. Consequently, these devices must undergo the premarket approval (PMA) process, which is the most stringent device marketing application procedure. These rigorous regulations can slow down the market's growth by extending development timelines and increasing costs.

Market Trends of the Global Biomaterials Market

A prominent trend in the global biomaterials market is the growing demand for biomaterials in plastic surgery and wound healing applications. As the population increases and the costs associated with treating damaged or diseased organs rise, implantable devices are increasingly favored for their proven clinical efficacy. These devices are used as scaffolds for restoring both soft and hard tissue deformities, offering significant benefits in wound healing. They promote tissue growth, maintain volume and shape, and accelerate healing times. Major players in the industry are expanding their product offerings for these applications through strategic partnerships and acquisitions. For instance, Advanced Medical Solutions (AMS), a company specializing in surgical and wound care, acquired Biomatlante, a firm focused on surgical biomaterial technologies.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Trade Analysis
Customer & Buying Criteria Analysis
Ecosystem of the Market
Patent Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Biomaterials Market by Type

Market Overview
Metallic Biomaterials
- Stainless steel
- Titanium & titanium alloys
- Cobalt-chrome alloys
- Silver
- Gold
- Magnesium
- Other metallic biomaterials
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Polyvinylchloride
- Silicone rubber
- Nylon
- Polyetherether ketone
- Other polymeric biomaterials
Ceramic Biomaterials
- Calcium phosphate
- Zirconia
- Aluminum oxide
- Calcium sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic acid
- Collagen
- Fibrin
- Cellulose
- Chitin
- Alginates
- Gelatin
- Chitosan
- Silk
- Other natural biomaterials

Biomaterials Market by Application

Market Overview
Orthopedic
- Joint Replacement
- Knee replacement
- Hip replacement
- Shoulder replacement
- Other joint replacement procedures
- Bioresorbable Tissue Fixation
- Suture anchors
- Mesh Screens
- Ultrasonic Vibrations
- Interference screws
- Meniscal repair tacks
- Meshes
- Spine Surgery
- Spinal fusion
- Minimally invasive fusion
- Motion preservation & dynamic stabilization
- Pedicle-based rod systems
- Interspinous spacers
- Artificial discs
- Fracture Fixation
- Bone plates
- Screws
- Pins
- Rods
- Wires
- Orthobiologics
Cardiovascular
- Catheters
- Stents
- Implan
- Pacemakers
- Sensors
- Heart valves
- Vascular grafts
- Guidewires
- Other cardiovascular products
Ophthalmology
- Contact lenses
- Intraocular lenses
- Functional replacement of ocular tissue
- Synthetic corneas
- Other ophthalmology products
Dental
- Dental implants
- Dental bone grafts & substitutes
- Dental membranes
- Tissue regeneration materials
Plastic Surgery
- Soft tissue fillers
- Craniofacial surgery products
- Facial wrinkle treatment devices
- Bioengineered skins
- Peripheral nerve repair devices
- Acellular dermal matrices
- Wound healing
- Wound closure devices
- Sutures
- Staples
- Surgical Hemostats
- Internal tissue sealants
- Adhesion barriers
- Hernia meshes
- Skin substitutes
Tissue Engineering
- Scaffolds
- Nanomaterials
- Inorganic nanoparticles
Neurological/ Central Nervous System
- Shunting systems
- Cortical neural prosthetics
- Hydrogel scaffolds
- Neural stem cell encapsulation products
Urinary
- Urinary catheters
- Urethral stents
- Other urinary products
Other Applications
- Drug delivery systems
- Gastrointestinal
- Bariatric surgery

Biomaterials Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

BASF SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covestro AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celanese Corporation (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carpenter Technology (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Terumo Biomaterials Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evonik Industries AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Xylos Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Victrex Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mitsubishi Chemical Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GELITA AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corbion (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solvay SA (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AB Specialty Silicones (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CoorsTek (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CeramTec GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Royal DSM NV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Lubrizol Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Berkeley Advanced Biomaterials (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zeus Industrial Products, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Noble Biomaterials, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dimension Inx (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Artoss, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RDI Group (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Riton Biomaterial Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cam Bioceramics (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments